Johnson & Johnson is reportedly exploring the sale of its orthopedic business, with an estimated valuation of over $20 billion US dollars.

According to sources familiar with the matter, Johnson & Johnson is considering selling its planned spin-off orthopedic division, and large private equity firms have begun to show interest in potential transactions. The sources, who requested anonymity to discuss the non-public information, revealed that the business, known as DePuy Synthes, could be valued at over $20 billion when sold. These sources also stated that Johnson & Johnson is preparing relevant documents and financial information for DePuy Synthes in order to meet with potential buyers in the coming weeks. They also mentioned that several large private equity firms are considering a joint acquisition of the business.